A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

• Status: Completed
• Trial end date: 2010-02-18

Summary

The purpose of this study is to evaluate the efficacy of three different concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution compared to placebo in the treatment of dry eye.

• Phase: Phase 2

Details

• Lead Sponsor: Shire
• Treatments: Lifitegrast; Ophthalmic Solutions; Pharmaceutical Solutions